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Abstract
The inhibitory receptor programmed death-1 (PD-1) has the capacity to maintain peripheral tolerance and limit
immunopathological damage; however, its precise role in fulminant viral hepatitis (FH) has yet to be described. Here, we
investigated the functional mechanisms of PD-1 as related to FH pathogenesis induced by the murine hepatitis virus strain-3
(MHV-3). High levels of PD-1-positive CD4
+, CD8
+ T cells, NK cells and macrophages were observed in liver, spleen, lymph
node and thymus tissues following MHV-3 infection. PD-1-deficient mice exhibited significantly higher expression of the
effector molecule which initiates fibrinogen deposition, fibrinogen-like protein 2 (FGL2), than did their wild-type (WT)
littermates. As a result, more severe tissue damage was produced and mortality rates were higher. Fluorescence double-
staining revealed that FGL2 and PD-1 were not co-expressed on the same cells, while quantitative RT-PCR demonstrated
that higher levels of IFN-c and TNF-a mRNA transcription occurred in PD-1-deficient mice in response to MHV-3 infection.
Conversely, in vivo blockade of IFN-c and TNF-a led to efficient inhibition of FGL2 expression, greatly attenuated the
development of tissue lesions, and ultimately reduced mortality. Thus, the up-regulation of FGL2 in PD-1-deficient mice was
determined to be mediated by IFN-c and TNF-a. Taken together, our results suggest that PD-1 signaling plays an essential
role in decreasing the immunopathological damage induced by MHV-3 and that manipulation of this signal might be a
useful strategy for FH immunotherapy.
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Introduction
Although liver transplantation has emerged as an effective
therapeutic approach for treating fulminant virus hepatitis (FH),
mortality rates associated with FH remain very high worldwide
[1]. The recent development of a mouse FH model, based upon
infection with the murine hepatitis virus strain-3 (MHV-3), has
provided insights into mechanisms underlying the disease
pathogenesis and resulted in some novel treatment strategies [2].
MHV-3 is a single-stranded, positive-sense RNA virus that
belongs to the Coronaviridae family. In inbred laboratory mice, the
virus produces strain-dependent disease profiles that depend on the
infection route, age, genetic background, and immune status of the
host. For example, Balb/c, C57BL/6 and DBA/2 mice develop
acute fulminant hepatitis, while C3H mice develop a mild chronic
disease and mice of the A strain exhibit no evidence of hepatitis
[3,4]. In contrast to the resistant A strain mice, FH induced by
MHV-3 in susceptible mice is characterized by the presence of
sinusoidal thrombosis and hepatocellular necrosis [2,3]. These
pathological findings occur concomitantly with expression of
fibrinogen-like protein 2 (FGL2), a virus-induced procoagulant
molecule in the sinusoidal lining cells in the liver. FGL2 has the
capacity to promote fibrinogen deposition and subsequently directly
induce the coagulation cascades by the expression of procoagulant
activity (PCA) [5]. Thus, up-regulation of FGL2 is an essential
component of the lethal effects of MHV-3-induced FH.
Programmed death (PD)-1 is an inhibitory receptor expressed
on activated T cells, B cells and myeloid cells. PD-1-deficient mice
(Pdcd1
2/2) develop various spontaneous autoimmune diseases,
including glomerulonephritis and dilated cardiomyopathy, indi-
cating that this receptor plays a critical role in maintenance of
peripheral tolerance [6]. PD-L1 (B7-H1) and PD-L2 (B7-DC), two
immunoregulatory molecules belonging to the B7 superfamily,
were identified as ligands for PD-1, engagement of PD-1 with its
ligands mediates negative signaling events via recruitment of
phosphatases, such as SHP-2, and dephosphorylation of some
effector molecules involved in downstream T cell receptor (TCR)
signaling [7,8].
PD-1 signaling has also been shown to modulate the balance
between antimicrobial immune defense and immune-mediated
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severe hepatocellular injury than their wild-type (WT) littermates
in response to adenovirus infection [9]. In a herpes simplex virus
(HSV) stromal keratitis mouse model, blockade of PD-1 signaling
led to increased HSV-1-specific effector CD4
+ T cell expansion,
IFN-c production, and exacerbated keratitis [10]. A functionally-
significant high level of PD-1 expression has been found to be
maintained by exhausted CD8
+ T cells in mice chronically
infected with lymphocytic choriomeningitis virus (LCMV), in
primates exposed to simian immunodeficiency virus (SIV), and in
humans suffering from infection with human immunodeficiency
virus (HIV), hepatitis B or C virus (HBV or HCV), or human T-
lymphotropic virus (HTLV). However, blockade of the PD-1/PD-
Ls pathway efficiently restored the virus-specific effector functions
of the exhausted T cells, and lead to substantially reduced in viral
load [11,12,13,14,15]. The PD-1 signal is also known to play a key
role in the chronicity of infections with bacteria (Helicobacter pylori
and Schistosoma mansoni) [16,17], pathogenic fungus (Histoplasma
capsulatum) [18], and parasitic worms (Taenia crassiceps) [19]. It
appears that a number of pathogenic microorganisms exploit the
PD-1 signal in order to evade host immune responses and to
establish persistent infection.
Although the influence of PD-1 signal activity has been studied
in several infection models, there are no data available concerning
the role of this pathway in FH. To this end, we used the MHV-3-
induced mouse FH model to demonstrate that PD-1 signaling acts
to limit the immunopathological damage during disease progres-
sion. Furthermore, our findings suggested that enhanced PD-1
signaling might represent a useful immunotherapeutic strategy for
treating FH.
Results
PD-1 expression on immune cells increased in response
to MHV-3 infection
PD-1 expression has been previously described as being induced
on specific cell subsets in response to viral or bacterial infection
[20]. Thus, we first determined the status of PD-1 expression at
72 h after MHV-3 infection (10 PFU) by immunohistochemical
techniques. PD-1-positive cells were observed in tissues from the
thymus, spleen, lymph nodes and liver. Cellular expression was
localized to the cell membrane and in the cytoplasma while was
completely absent from the nuclear compartment. PD-1-positive
cells were distributed throughout the medulla and cortex of the
thymus and lymph nodes. In the spleen, PD-1-positive cells were
restricted to the germinal center under normal conditions, but
extended to the red pulp after infection. In infected liver, more
PD-1-positive cells were present in the portal and parenchymal
areas, as opposed to the relatively low presence of PD-1-positive
cells in only the portal area in phosphate-buffered saline (PBS)
treated-mice (Fig. 1A). The amount of PD-1-positive cells in the
different organs of infected and control mice were counted and
compared, results showed that the number of positive cells was
significantly higher in infected mice (Fig. 1B). Furthermore, FACS
analysis revealed that PD-1 expression was enhanced on multiple
subsets of immune cells, including the CD4
+ and CD8
+ T cells,
NK1.1
+ NK cells and CD68
+ macrophages (Fig. 1C). PD-1-
positive cells were also observed in the lung, heart and kidney,
however, the numbers of PD-1 positive cells in these tissues did not
significantly increase in response to MHV-3 infection (Fig. S1).
PD-1-deficient mice experienced multiple organ damage
following MHV-3 infection
To investigate the potential role of PD-1 signaling in regulating
FH tissue pathology, organs from MHV-3 infected PD-1-deficient
(PD-1 KO) and WT mice were assessed for morphological
differences. Small and discrete foci of necrosis with sparse
polymorphonuclear leukocyte infiltration were observed in liver
tissues from PD-1-deficient mice after 24 h of infection. In
contrast, WT mice exhibited normal liver architecture at this
time point. Slight liver damage became apparent in WT mice after
48 h of infection, meanwhile, the damaged areas of PD-1-deficient
mice had enlarged and confluent necrosis had become evident. By
72 h of infection, the damaged region in PD-1-deficient mice had
extended throughout the entire liver, while WT mice suffered
much less damage and up to 60% of their liver tissue remained
normal at this time point (Fig. 2A). Likewise, higher levels of
alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) were observed in serum from PD-1-deficient mice after 72 h
of infection (Fig. 2B). More interestingly, PD-1-deficient thymus,
spleen and lymph node tissues infected with MHV-3 for 72 h
exhibited severely disrupted architecture, loss of cellularity, and
the presence of substantial amounts of karyorrhectic/apoptotic cell
bodies. The histology of these organs from infected WT mice at
72 h was relatively normal (Fig. 2C). In conjunction with the
apparent tissue necrosis, higher levels of cell apoptosis were also
evidenced in the organs from PD-1-deficient mice by TUNEL
staining (Fig. 2D). The architecture of other organs, including the
heart, kidney and lung was relatively normal and only rare
apoptosis events were observed in these tissues after infection (Fig.
S2). In all, these results demonstrated that PD-1 deficiency led to
enhanced pathological damage by MHV-3 in the liver, spleen,
lymph node and thymus, where higher levels of PD-1-positive cells
were found after infection.
PD-1-deficient mice displayed higher mortality rates
associated with MHV-3 infection
The earlier and increased organ damage suffered by PD-1-
deficient mice infected with MHV-3 instigated our monitoring of
the mortality rates of PD-1-deficient mice and their similarly-
infected (10 PFU) WT littermates. As shown in Fig. 3, all of the
PD-1-deficient mice died within four days after infection, while
Author Summary
The principal characteristic of fulminant viral hepatitis (FH)
induced by the murine hepatitis virus strain-3 (MHV-3) is
severe hepatocellular necrosis, which is mediated by the
fibrinogen-like protein 2 (FGL2), a molecule that has the
capacity to promote fibrinogen deposition and activate
the coagulation cascades. Here, we report that MHV-3
infection of program death-1 (PD-1)-deficient mice results
in tissue damage throughout multiple organs, including
the liver, spleen, thymus and lymph nodes. The liver
damage, in particular, occurred earlier and was more
severe in PD-1-deficient mice than in their wild type (WT)
littermates. Further investigation determined that MHV-3
infection was associated with high levels of IFN-c and
TNF-a in the damaged organs of PD-1-deficient mice.
Conversely, intraperitoneal injection of a combination of
anti-IFN-c and anti-TNF-a blocking mAbs led to inhibition
of FGL2 expression, greatly attenuated tissue lesions and
reduced mortality. Our results demonstrate that PD-1
signaling controls immunopathological damage following
MHV-3 infection, indicating that manipulation of the PD-1
signal might represent a useful strategy for FH immuno-
therapy.
PD-1 Limits Immunopathological Damage
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period (p=0.007). These data indicated that PD-1 is likely a
critical factor that controls MHV-3-mediated tissue damage and
mortality.
Elevated FGL2 expression was induced in PD-1-deficient
mice following MHV-3 infection
To understand the mechanisms of PD-1 deficiency-mediated
tissue damage and mortality, we performed a comparative
genome-wide microarray analysis (NimbleGen) of genes expressed
in liver tissues of PD-1-deficient and WT mice after 72 h of MHV-
3 infection. The most notable finding was pronounced up-
regulation (3.75-fold) in the liver of PD-1-deficient mice of the
fgl2 transcripts (Fig. 4A), the protein product of which has been
demonstrated to induce lethality of MHV-3-induced FH [5]. In
addition, the enhanced fgl2 expression was confirmed by
quantitative (q)PCR, results revealed a 2.84-fold and 5.72-fold
higher level was present in liver from WT and PD-1-deficient
mice, respectively, after 72 h of MHV-3 infection, as compared to
their uninfected controls. Moreover, its level in PD-1-deficient
liver was 2.01-fold higher than that in the WT group at this time
point (Fig. 4B). Immunohistochemistry was used to show that
FGL2-positive cells were present in necrotic liver tissues in PD-1-
deficient mice at 24 h after MHV-3 injection. The protein
expression was found to be enhanced rapidly upon infection, and
the highest level occurred at 72 h post-infection. However,
occasional FGL2-positive cells were detected in the livers of WT
mice at 24 h post-MHV-3 infection and these cells were also
present, and slightly enhanced in number, at both the 48 h and
72 h time point (Fig. 4C). Western-blot was used to verify the
higher FGL2 protein level in the livers of PD-1-deficient mice, as
compared to WT littermates after 72 h of infection (Fig. 4D).
FGL2 has the capacity to induce fibrinogen deposition, which
then activates the coagulation cascades and finally induces
procoagulant activity. Therefore, the expression of FGL2 and
fibrinogen deposition in damaged liver tissues was measured. Dual
fluorescent staining evidenced that substantial fibrinogen deposi-
tion occurred in the FGL2-positive damaged liver tissue (Fig. 4E).
Figure 1. Enhanced expression of PD-1 on immune cells after 72 h of MHV-3 infection. (A) Immunohistochemical detection of PD-1
expression in mouse thymus, spleen, lymph nodes and liver. (B) Statistical analysis of the number of PD-1-positive ells in the indicated organs from
MHV-3 infected mice or PBS-treated controls. (C) The expression of PD-1 on immune cells, including CD4
+, CD8
+ T cells, CD68
+ macrophages and
NK1.1
+ NK cells in the indicated organs after 72 h of MHV-3 infection was measured by FACS. The number indicates the percentage of the positive
cells in the indicated gate. One representative of three experiments which yielded similar results is shown. Magnification 6200. *p,0.05, **p,0.01.
n=8/group.
doi:10.1371/journal.ppat.1001347.g001
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livers from PD-1-deficient mice that in livers from WT littermates,
at both the 48 h and 72 h time points (Fig. 4F).
To determine whether FGL2-mediated PCA activity was also
involved in inducing damage in the other organs of PD-1-deficient
mice, the expression of FGL2 was analyzed in the thymus, spleen
and lymph nodes. Immunohistochemistry evidenced that FGL2-
positive cells were also present in these organs. In thymus and
lymph nodes, FGL2-positive cells were detected in both the
medulla and cortex. In spleen, however, the positive cells were
only found in the red pulp. Again, the expression of FGL2
appeared to be restricted to the cell membrane and cytoplasma.
The distribution of FGL2-positive cells in PD-1-deficient mice had
not changed after 72 h of MHV-3 infection, but the number of
positive cells in the examined organs was enhanced significantly
and the levels of expression were much stronger (Fig. 5A). In
addition, the transcription of fgl2 in the spleen of PD-1-deficient
mice was also significantly increased in response to infection
(Fig. 5B). Meanwhile, higher levels of fibrinogen deposition were
found in the spleen and lymph node tissues of PD-1-deficient mice
(Fig. 5C). Moreover, the level of FGL2 present in serum, as
measured by ELISA, was found to increase rapidly after infection,
and the level in PD-1-deficient mice was significantly higher than
that in WT littermates (Fig. 5D). To clarify the source of FGL2,
fluorescent dual staining was performed on spleen tissues and
results demonstrated that FGL2 was principally associated with
CD11c-positive dendritic cells (DCs), CD68-positive macrophages
and CD31-positive endothelial cells (Fig. 5E). All of these results
indicated that the absence of PD-1 signaling can result in
enhanced FGL2 expression, consequently inducing stronger
fibrinogen deposition and more severe tissue necrosis in PD-1-
deficient mice following MHV-3 infection.
FGL2 expression is regulated by IFN-c and TNF-a
We further examined whether FGL2 secretion was regulated by
PD-1 directly or indirectly. FGL2/PD-1 dual fluorescent staining
was performed and results indicated that FGL2 and PD-1 were
not co-expressed on the same cells in the liver, thymus, spleen or
lymph nodes (Fig. 6A).
Previous studies have shown that the secretion of FGL2 can be
triggered by the pro-inflammatory factors IFN-c and TNF-a
[21,22]. On the other hand, the production of IFN-c and TNF-a
by activated T cells, NK cells and macrophages can be inhibited
by the PD-1 signal [6]. Therefore, we compared the status of IFN-
c and TNF-a in PD-1-deficient and WT mice in response to
MHV-3 infection. qPCR revealed that the transcription of the
IFN-c gene in liver was significantly higher in PD-1-deficient mice
than in WT mice at 72 h post-MHV-3 infection (Fig. 6B). In PD-
1-deficient spleen, the transcription of both IFN-c and TNF-a was
found to be rapidly enhanced upon MHV-3 exposure (Fig. 6C).
FACs analysis indicated that IFN-c secretion from NK cells, but
not from CD3
+T cells, in the liver was much higher in PD-1-
deficient mice at 72 h after MHV-3 infection (Fig. 6D). The fact
that IFN-c and TNF-a both have the capacity to initiate FGL2
expression may explain why higher FGL2 expression was observed
in the PD-1-deficient mice.
To further demonstrate that IFN-c and TNF-a were responsible
for the observed FGL2 up-regulation in MHV-3 infected PD-1-
deficient mice, PD-1-deficient mice were infected with MHV-3
and simultaneously treated with a combination injection of anti-
IFN-c and anti-TNF-a blocking mAbs. The expression of fgl2 was
measured by qPCR and protein detected by immunohistochem-
istry. The transcription of fgl2 mRNA (Fig. 7A) and its protein
levels (Fig. 7B) were completely inhibited by 48 h after injection of
anti-IFN-c and anti-TNF-a mAbs, as compared to the control rat
IgG1 isotype antibodies-treated group. Moreover, the tissue
necrosis (Fig. 7C) and liver damage (as indicated by ALT and
AST levels) (Fig. 7D) in PD-1-deficient mice were also significantly
reduced, thus the MHV-3-mediated mortality rates were de-
creased as well (Fig. 7E).
Discussion
The PD-1 signaling is best known for its ability to inhibit or
dampen the immune response. Most of the evidence for this
function, however, comes from models of tolerance or chronic
infections [11, 12, 13, 14 15]. Although some studies have
indicated that this signal might also participate in regulating acute
infections [23,24,25,26], its functions in this disease condition are
much less clear. Here, we used a mouse FH model mediated by
MHV-3 infection to describe the effects of PD-1 in this disease
process. Firstly, PD-1 was found to be significantly up-regulated on
T cells, macrophages and NK cells within the thymus, spleen,
lymph nodes and liver in response to MHV-3 infection. To
determine the exact role of PD-1 in the pathogenesis of FH, PD-1-
deficient mice were used to establish an infection model.
Interestingly, MHV-3-induced liver damage in PD-1-deficient
mice occurred rapidly and the lesion area was much larger than in
their WT littermates. We then extended our investigation to the
thymus, spleen and lymph nodes, where increased PD-1-positive
Figure 3. PD-1-deficiency resulted in higher mortality after
MHV-3 infection. PD-1-deficient mice (n=11) and WT littermates
(n=13) were infected with MHV-3 (10 PFU) and the survival rate was
monitored for a total of 15 days. p=0.007,0.05 was considered
significantly different. One representative of four experiments that
yielded similar results is shown.
doi:10.1371/journal.ppat.1001347.g003
Figure 2. Multiple organ damage in PD-1-deficient mice after MHV-3 infection. (A) The architecture of liver from PD-1-deficient mice and
WT littermates at different time points after MHV-3 infection was compared by H&E staining. (B) The ALT and AST levels between PD-1-deficient and
WT mice were compared after MHV-3 infection. (C) The architecture of the thymus, spleen and lymph node from PD-1-deficient mice and WT
littermates after 72 h of MHV-3 infection was compared by H&E staining. (D) Cellular apoptosis in the liver (0 h, 24 h and 72 h), thymus (72 h), spleen
(72 h), and lymph nodes (72 h) from WT and PD-1-deficient mice after MHV-3 infection was analyzed by TUNEL staining. Blue color indicates nuclear
DAPI staining. Scale bar =20 mm. Magnification 6200. NS: not significantly different. *p,0.05 and **p,0.01. n=4/group.
doi:10.1371/journal.ppat.1001347.g002
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PLoS Pathogens | www.plospathogens.org 5 July 2011 | Volume 7 | Issue 7 | e1001347Figure 4. Higher FGL2 expression and stronger fibrinogen deposition in the liver of PD-1-deficient mice after MHV-3 infection. (A)
The transcription levels of fgl2 in livers from PD-1-deficient and WT mice after 72 h of MHV-3 infection was detected by microarray analysis. (B) The
transcription levels of fgl2 in livers from PD-1-deficient and WT mice after MHV-3 infection was detected by qPCR. (C) The expression of FGL2 in the
livers of PD-1-deficient mice and WT littermates after MHV-3 infection was analyzed by immunohistochemistry. (D) The FGL2 protein level in liver
tissues was detected by Western-blot (72 h of infection). (E) The expression of FGL2 and fibrinogen deposition in the liver was detected by
fluorescent dual staining. (F) The deposition of fibrinogen in the liver of PD-1-deficient mice and WT controls at 0 h, 48 h and 72 h post MHV-3
PD-1 Limits Immunopathological Damage
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necrosis and substantial apoptosis was observed in these organs
of PD-1-deficient mice at 72 h after MHV-3 infection. In contrast,
these organs from WT mice exhibited relatively normal histology,
a finding in agreement with previously reported results [27].
Taken together, these results suggested that PD-1 deficiency
promoted expansion of the pathological damage from the liver to
the lymph organs, including the spleen, lymph node and thymus in
this FH model, thereafter, the absence of PD-1 was associated with
higher mortality rates in response to MHV-3 infection.
Murine FH induced by MHV-3 is a recognized and validated
model for studying host resistance/susceptibility to human
hepatitis virus, and several studies have shown that BALB/c or
C57BL/6 mice have an innate susceptibility to the infection [3,4].
FGL2 has been proposed as a critical mediating factor of lethality
in the MHV-3-induced FH mice due to the fact that it has the
capacity to induce fibrinogen deposition, which in turn activates
the coagulation cascades and induces procoagulant activity [5]. To
clarify whether the tissue necrosis we observed in PD-1-deficient
mice following infection was also mediated by FGL2, the
expression of FGL2 was analyzed. Results showed that the
expression of FGL2 was principally associated with CD31-positive
endothelial cells, CD68-positive macrophages and CD11c-positive
DCs. Surprisingly, significantly higher levels of FGL2 were
observed after infection in all of PD-1-deficient organs, including
the liver, thymus, spleen, lymph nodes, and serum than that in
those from WT littermates. In addition, increased fibrinogen
deposition was observed in the organs of PD-1-deficient mice.
Although we currently have no direct data to evidence that FGL2
directly mediates the mortality of our PD-1-deficient mice, data
from other researchers have clearly shown that FGL2 promoted
mouse mortality in response to MHV-3 infection [5,28,29,30].
Considering this, our results strongly indicate that the mortality of
PD-1-deficient mice post-MHV-3 infection is due to the higher
level of FGL2 secretion and increased fibrinogen deposition.
Indeed, it has been reported that both FGL2 and PD-1 are
expressed on T cells, macrophages, and DCs, and that targeted
deletion of fgl2 or PD-1 leads to impaired T cell activity, and these
events are related to the development of autoimmune diseases
[6,31,32]. We here also observed PD-1 expression as being
enhanced on T cells (both CD4
+ and CD8
+ T cells). It was
reasonable to propose that the expression of FGL2 may have been
directly regulated by PD-1 signals. Unexpectedly, our FGL2/PD-1
dual staining showed that PD-1-positive cells in the liver, thymus,
spleen and lymph nodes did not co-express FGL2, indicating that
the expression of FGL2 was not directly regulated by PD-1. On
the other hand, the expression of FGL2 is believed to be induced
by IFN-c and TNF-a [21,22], while PD-1 signaling has the
capacity to inhibit IFN-c and TNF-a secretion from PD-1-positive
immune cells [6]. Therefore, we evaluated and compared the
status of IFN-c and TNF-a in both PD-1-deficient and WT mice.
Definitively, the transcription of IFN-c and TNF-a genes was
rapidly enhanced post-MHV-3 infection in PD-1-deficient mice,
as compared to WT controls. In particular, a higher level of IFN-c
was observed in NK cells but not in CD3
+ T cells of PD-1-
deficient liver post-MHV-3 infection, indicating that the PD-1
signal can inhibit IFN-c secretion from NK cells under such
condition. Conversely, injection of a the combination of anti-IFN-
c and anti-TNF-a blocking mAbs was able to successfully inhibit
fgl2 mRNA transcription and protein expression, resulting in
reduced tissue damage and significantly protecting against MHV-
3-mediated mortality in these mice. These results demonstrated
that up-regulation of FGL2 in PD-1-deficient mice after MHV-3
infection was controlled, at least partially, by IFN-c and TNF-a.
Recently, the secretion of FGL2 from naturally occurring
CD4
+Foxp3
+ regulatory T cells (Tregs) was demonstrated and it
was reported that deficiency of Treg-produced FGL2 resulted in
increased effector T cell proliferation [32]. More interestingly,
Levy and colleagues showed that the frequency of FGL2
+ Tregs
was higher in lymphoid tissues of MHV-3 infected mice, and
treatment with FGL2-specific antibodies reversed MHV-3-
induced liver injury and mortality in vivo. These findings
demonstrated that FGL2 is an important effector cytokine of
Tregs that contributes to MHV-3-induced FH [30]. PD-1
signaling has also been described as participating in regulation
of Treg differentiation and function [33,34]. In our study, we also
analyzed the status of Foxp3
+ cells in both PD-1-deficient and WT
controls. However, the number of Foxp3-positive cells in the liver,
spleen, lymph node or thymus was not significantly different
between PD-1-deficient mice and their WT littermates after 72 h
of MHV-3 infection (Fig. S3). Therefore, Foxp3
+ cells are unlikely
to be involved in the mortality of PD-1-deficient mice. However,
the functional status of these Tregs (for example, the level of FGL2
secretion) in PD-1-deficienct mice requires further investigation,
and such studies are in progress in our lab.
In conclusion, we have determined that PD-1 signaling can limit
the immunopathological damage induced by MHV-3 infection in
a mouse FH model. Our results suggest that enhancing the PD-1
signal by an immunotherapeutic approach might be a useful
treatment for FH.
Materials and Methods
Ethics statement
All experiments were approved by and conducted in accordance
with the guidelines of the Animal Care and Use Committee of the
Third Military Medical University. All efforts were made to
minimize animals’ suffering.
Mice
PD-1-KO-N10 (strain: BALB/cJ) mice were kindly provided by
Prof. T. Honjo (Department of Immunology and Genomic
Medicine, Kyoto University, Japan). The WT control mice were
purchased from the Animal Center of Beijing University School of
Medicine. All mice were maintained in micro-isolator cages and
housed in the animal colony at the Animal Center, Third Military
Medical University, standard laboratory chow diet and water was
supplied ad libitum. Mice were used in experimental analysis at age
of six weeks and at an average weight of 17 g (range: 16,18 g).
Virus and infection
MHV-3 was kindly provided by Prof. Q. Ning (Institute of
Infectious Disease, Tongji Hospital of Tongji Medical College,
Wuhan, China). The virus was plaque-purified and then
expanded in murine L2 cells. Virus-containing supernatants were
collected and stored at -80uC until use. Mice were intraperito-
neally (i.p.) injected with 10 PFU/mouse in a total volume of
200 ml. In some experiments, PD-1-deficient mice were infected
with MHV-3 (10 PFU) and simultaneously treated with a
infection was analyzed by immunohistochemistry. Blue color indicates nuclear DAPI staining. Scale bar =20 mm. Magnification 6200. NS: not
significant different. *p,0.05, ** p,0.01.
doi:10.1371/journal.ppat.1001347.g004
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clone: R4-6A2, eBioscience, San Diego, CA, USA) and anti-
TNF-a (200 mg/mouse per day, clone: MP6-XT22, eBioscience)
mAbs, tissues were isolated for hematoxylin and eosin (H&E)
staining to detect damage, and for fgl2 mRNA transcription
measured by qPCR (see below). Serum ALT and AST levels were
measured by an AU5400 automatic biochemistryanalyzer
(OLYMPUS, Japan). In order to monitor the mortality, anti-
IFN-c and anti-TNF-a blocking mAbs or rat IgG1 control mAbs
were injected everyday for a total of 6 days.
Immunohistochemical and immunofluorescence staining
Paraffin-embedded tissue blocks were cut into 5 mm slices which
were mounted on polylysine-charged glass slides. Endogenous
peroxidase activity was blocked by exposure to 3.0% H2O2 for
15 min. Antigen retrieval was performed in a citrate buffer
(pH 6.0) at 120uC for 10 min. Sections were then incubated at
4uC overnight with anti-mouse FGL2 (1:100, mouse IgG, Santa
Cruz, CA, USA), PD-1 (5 mg/ml, goat IgG, R&D Systems,
Minneapolis, MN, USA), CD11c (1:50, rabbit IgG, Santa Cruz),
CD68 (1:50, rat IgG, eBioscience), CD31 (1:100, rabbit IgG,
Santa Cruz) or fibrinogen (1:100, mouse IgG1, Dako, Capenteria,
CA, USA). Immunoreactivity was detected by using a fluorescein
isothiocyanate (FITC)-conjugated (1:100, Zymed, San Francisco,
CA, USA) or Cy3-conjugated secondary antibodies (1:200;
Jackson ImmunoResearch, West Grove, PA, USA). Results were
analyzed by fluorescence microscopy (Axioplan 2, Zeiss, Ger-
many). For immunohistochemical staining, HRP-conjugated anti-
mouse, anti-goat or anti-rabbit IgG (1:200, Zymed) was used, and
the results were visualized with diaminobenzidine (DAB, Dako).
Sections incubated with secondary antibodies only were used as
isotype controls.
Figure 5. Enhanced FGL2 expression in the thymus, spleen, lymph nodes and serum of PD-1-deficient mice after MHV-3 infection.
(A) The expression of FGL2 in the thymus, spleen and lymph nodes of PD-1-deficient mice and their WT littermates was detected by
immunohistochemistry (left) and the amounts of FGL2-positive cells in these organs were counted and compared (right). (B) The fgl2 mRNA
transcription in the spleens of PD-1-deficient mice and their WT littermates after MHV-3 infection was measured by qPCR. (C) The fibrinogen
deposition in the spleen and lymph nodes was detected by immunohistochemistry. (D) The differential serum FGL2 level between PD-1 deficient and
WT mice infected with MHV-3 was measured by ELISA. (E) The source of FGL2 was analyzed by fluorescent dual staining. Blue color indicates nuclear
DAPI staining. Scale bar =20 mm. Magnification 6200. NS: not significantly different. *p,0.05, **p,0.01 and ***p,0.001. n=5/group.
doi:10.1371/journal.ppat.1001347.g005
Figure 6. MHV-3 infection induced high levels of IFN-c and TNF-a in PD-1-deficient mice. (A) The expression of FGL2 and PD-1 in liver,
thymus, spleen and lymph nodes was detected by fluorescent dual staining. (B) Levels of IFN-c and TNF-a mRNA in the liver and (C) in the spleen
from PD-1-deficient mice and their WT littermates after MHV-3 infection was detected by qPCR. (D) The secretion of IFN-c from NK cells and CD3
+T
cells in the liver from PD-1-deficient mice and their WT littermates after 72 h of MHV-3 infection was measured by FACs. The number indicates the
percentage of the positive cells in the indicated gate. One representative of three experiments that yielded similar results is shown. Blue color
indicates nuclear DAPI staining. Scale bar =20 mm. NS: not significantly different. *p,0.05.
doi:10.1371/journal.ppat.1001347.g006
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PLoS Pathogens | www.plospathogens.org 10 July 2011 | Volume 7 | Issue 7 | e1001347PD-1-, FGL2- or Foxp3-positive cells were determined by image
analysis of histological sections. Photomicrographs were obtained
in high-power fields (hpf, 0.625 mm
2) and captured for analysis
using Image Pro-Plus 5.0 software (Media Cybernetics, Silver
Spring, MD, USA). The distribution of FGL2 and Foxp3 in
thymus and lymph node is restricted in medulla and only the
positive cells in this area were calculated. The number of PD-1-,
FGL2- or Foxp3-positive cells per hpf were counted and expressed
as the mean 6 standard error of the mean (SEM). Moreover,
analysis of tissue damage was based on H&E staining.
Flow cytometry
The expression of PD-1 on immune cells (CD4, CD8, NK and
macrophages) from different organs was assessed by flow
cytometry (FACsAria Cytometer; Becton Dickinson, Germany).
Briefly, cell suspensions of liver, spleen, blood and thymus tissues
were washed and resuspended in PBS. Cells were then incubated
for 30 min at room-temperature in the dark using primary
antibodies (PE-PD-1, FITC-CD4, FITC-CD8, FITC-NK1.1 and
FITC-CD68. eBioscience). To analyze the source of IFN-c in the
liver, PD-1-deficient and WT mice were treated with MHV-3 (10
PFU). After 72 h, liver tissues were isolated and mechanically
homogenized, lymphocytes were collected thereafter. Cells were
then treated with Brefeldin A solution (BFA) for 4 h, and FITC-
NK1.1, FITC-CD3 or PE-IFN-c mAbs (eBioscience) were added
and the solution incubated for an additional 1 h. For each analysis,
10000 cells were evaluated. Flow cytometric data were analyzed
with CellQuest Pro Software.
Microarray analysis
The microarray experiment was performed under contact by
Kangcheng Co. Ltd. (Shanghai, China). Briefly, total RNA was
isolated by Trizol from liver tissue of PD-1-deficient and WT mice
treated with 10 PFU MHV-3 for 72 h. RNA concentration was
measured on the ND-1000 spectrophotometer (Nanodrop,
Wilmington, DE, USA) and quality evaluated by denaturing gel
electrophoresis. Samples were then amplified and labeled using a
NimbleGen One-Color DNA Labeling Kit and hybridized using
the NimbleGen Hybridization System (Roche Applied Science,
Shanghai, China). After hybridization and washing, the processed
slides were scanned by the Axon GenePix 4000B microarray
scanner. Three independent experiments were performed, and for
each test and control sample, two hybridizations were carried out
by a reverse fluorescent strategy. Only genes whose alteration
tendency was concordant between both microarray assays were
selected as differentially expressed genes.
Quantitative RT-PCR
Total RNA from the liver and spleen of WT and PD-1-deficient
mice was isolated by Trizol (Invitrogen, Carlsbad, CA, USA),
according to the manufacturer’s instructions. RNA samples were
quantitated by measurement of optical density at 260 nm. Total
mRNA (2 mg) was reverse-transcribed to cDNA using the
RevertAid H Minus First Strand cDNA Synthesis Kit (Fermentas
China, Shenzhen City, China), in accordance with the manufac-
turer’s instructions. qPCR was performed to quantitatively analyze
the gene transcription levels of fgl2, IFN-c and TNF-a genes. The
primers for fgl2 were: sense 59-TGGACAACAAAGTGG-
CAAATCT-39 and anti-sense 59-TGGAACACTTGCCATC-
CAAA-39. The primers for IFN-c were: sense 59-TCAAGTGG-
CATAGATGTGGAAG-39, and anti-sense 59-CGCTTATG-
TTGTTGCTGATGG-39. The primers for TNF-a were: sense
59-CACGCTCTTCTGTCTACTGAAC-39 and anti-sense 59-
ATCTGAGTGTGAGGGTCTGG-39. The primers for b-actin
(internal control) were: sense 59-CACTATCGGCAATGAG-
CGGTTCC-39 and anti-sense 59-CAGCACTGTGTTGGCA
TAGAGGTC-39. The qPCR was performed at 95uC for 10 s
followed by 40 cycles of 95uC for 5 s, 60uC for 15 s, and 72uC for
15 s. The specificity of PCR product was examined by a
dissociation curve, and results were analyzed by the 2
2DDCT
method [35].
Western-blot
The expression of FGL2 in liver from MHV-3 infected (72 h)
PD-1-deficient mice or their WT littermates was determined by
Western-blot; the protocol has been described previously [36].
Enzyme-linked immunosorbent assay (ELISA)
The serum FGL2 level from mice infected with or without
MHV-3 was detected by using the mouse FGL2 ELISA Kit (Cat:
E90512Mu; Uscn Life Science Inc., Wuhan, China) and following
the manufacturer’s instructions.
Statistical analysis
All results shown are representative of at least three separate
experiments. Unpaired student’s t-test (two-tailed) or the Mann-
Whitney test was used for comparison of two groups where
appropriate. Kaplan Meier curve with log-rank test (GraphPad
Prism 4.03 software) was used to analyze the mortality rate. p-
value ,0.05 was considered as statistically significant.
Supporting Information
Figure S1 The location of PD-1-positive cells in the lung, kidney
and heart from MHV-3 infected or PBS-treated mice was detected
by immunohistochemistry (left). Statistical analysis of the number
of PD-1-positive cells in the lung, kidney and heart tissue of MHV-
3 infected or PBS-treated mice (right). The arrow indicates the
PD-1-positive cells. Magnification 6600. NS: not significantly
different.
Found at: doi:10.1371/journal.ppat.1001347.s001 (2.05 MB TIF)
Figure S2 (A) The architecture of the lung, kidney and heart of
WT vs. PD-1-deficient mice after 72 h of MHV-3 infection was
measured by H&E staining. (B) Cell apoptosis in these organs was
detected by TUNEL staining. The arrow indicates the TUNEL-
positive cells. Blue color indicates nuclear DAPI staining. Scale
bar =20 mm. Magnification 6200.
Found at: doi:10.1371/journal.ppat.1001347.s002 (1.86 MB TIF)
Figure 7. Up-regulation of FGL2 in PD-1-deficient mice after MHV-3 infection is regulated by IFN-c and TNF-a. (A) Fgl2 mRNA and (B)
its protein expression in the liver, spleen and lymph node from PD-1-deficient mice after 72 h of MHV-3 infection in the presence of IFN-c and TNF-a
mAbs or rat IgG1 isotype control antibodies was detected by qPCR and immunohistochemistry, respectively. (C) The IFN-c and TNF-a mAbs treatment
resulted in decreased damage to the liver, spleen, lymph node and thymus after 72 h of MHV-3 infection. (D) Reduced FGL2 level by IFN-c and TNF-a
mAbs treatment resulted in reduced liver damage (indicated by AST and ALT levels). (E) PD-1-deficient mice were infected with MHV-3 (10 PFU) and
simultaneously treated with IFN-c and TNF-a blocking mAbs (n=4) or rat IgG1 control (n=6), the survival rate was monitored for a total of 15 days.
p=0.025,0.05 was considered significantly different. One representative of three experiments that yielded similar results is shown. Magnification6
400. NS: not significantly different. *p,0.05 and **p,0.01. n=5/group.
doi:10.1371/journal.ppat.1001347.g007
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significantly in PD-1-deficient mice after MHV-3 infection.
Foxp3-positive cells in the liver, thymus, spleen, and lymph nodes
between PD-1-deficient and WT mice at 72 h after MHV-3
infection were detected by immunofluorescence staining (left).
Statistical analysis of the number of Foxp3-positive cells in the
indicated organs (right). Blue color indicates nuclear DAPI
staining. Scale bar =20mm. NS: not significantly different.
Found at: doi:10.1371/journal.ppat.1001347.s003 (1.44 MB TIF)
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